In a 2012 article titled “Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.,” medical researchers J Cookson, R Hodgson, and HJ Wildgust explored the association between hyperprolactinemia and antipsychotic use.
Hyperprolactinemia is an ailment characterized by increased blood levels of the hormone prolactin, which is responsible for breast growth and development. When men or women have hyperprolactinemia, breast growth is often the result. In men, this breath growth is called gynecomastia.
Cookson et al. (2012) write that “Hyperprolactinaemia is a common side effect of antipsychotics” and “Higher levels of prolactin result from longer exposure to higher doses, especially with older antipsychotics or with risperidone, sulpiride or amisulpride.” (emphasis added)
“Galactorrhoea, gynaecomastia, menstrual abnormalities and sexual dysfunction including hypogonadism and fertility problems are consequences of raised prolactin, and in the longer-term bone demineralisation.” (emphasis added)
Sadly, the manufacturer of the drug most readily associated with hyperprolactinemia – Risperdal (risperidone), of Janssen Pharmaceuticals, Inc., failed time and again to warn users of the risk for male breast growth associated with Risperdal, Risperdal lawsuits are currently being filed across the country.
If you or a loved one used Risperdal and suffered gynecomastia, you may be entitled to significant financial compensation through a Risperdal lawsuit of your own. For a free, no-obligation case consultation, contact our team of Risperdal lawyers at the information provided below. We have the compassion, resources, and experience required to win the justice you deserve.
(855) 452 – 5529
Our Risperdal Lawsuit Information page is a great place to start if you have any questions about Risperdal.